phosphoric acid,pyridine-3,4-diamine structure
|
Common Name | phosphoric acid,pyridine-3,4-diamine | ||
|---|---|---|---|---|
| CAS Number | 446254-47-3 | Molecular Weight | 207.12400 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C5H10N3O4P | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of phosphoric acid,pyridine-3,4-diamineAmifampridine (3,4-Diaminopyridine) phosphate is an orally active potassium channel blocker (PCB), can block presynaptic potassium channels[1]. Amifampridine phosphate can be used in Lambert-Eaton myasthenic syndrome (LEMS) research[1]. |
| Name | phosphoric acid,pyridine-3,4-diamine |
|---|---|
| Synonym | More Synonyms |
| Description | Amifampridine (3,4-Diaminopyridine) phosphate is an orally active potassium channel blocker (PCB), can block presynaptic potassium channels[1]. Amifampridine phosphate can be used in Lambert-Eaton myasthenic syndrome (LEMS) research[1]. |
|---|---|
| Related Catalog | |
| In Vivo | Amifampridine phosphate treatment (Intravenous injection; 2.5 mg/kg; once) shows 1 hour plasma half-life[2]. Amifampridine phosphate treatment (Oral administration; 10 mg/kg; once) shows plasma concentrations spike[2]. Animal Model: Mice[2] Dosage: 2.5 mg/kg Administration: Intravenous injection; 2.5 mg/kg; once Result: Had a plasma half-life of about 1 hour. Animal Model: Mice[2] Dosage: 10 mg/kg Administration: Oral administration; 10 mg/kg; once Result: Exhibited a rapid spike in plasma concentrations. |
| References |
| Molecular Formula | C5H10N3O4P |
|---|---|
| Molecular Weight | 207.12400 |
| Exact Mass | 207.04100 |
| PSA | 153.23000 |
|
~%
phosphoric acid... CAS#:446254-47-3 |
| Literature: Guyon, Francois; Pradeau, Dominique; Le Hoang, My Dung; Houri, Jean-Jacques Patent: US2004/106651 A1, 2004 ; Location in patent: Page 3 ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| Amifampridine phosphate |
| 3,4-Diaminopyridine phosphate |
| UNII-8HF8FIN815 |
| Firdapse |
| Zenas |